TKTomoya Kitakaze

Tomoya Kitakaze

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomoya Kitakaze has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Hitoshi Ashida

    Department of Agrobioscience, Graduate School of Agricultural Science, Kobe University

    1 shared publication
  • Takashi Furuyashiki

    Institute of Health Sciences, Ezaki Glico Co., Ltd

    1 shared publication
  • Yasukiyo Yoshioka

    Graduate School of Science, Technology and Innovation, Kobe University

    1 shared publication

Latest Publications

  • Open Access

    Enzymatically synthesized glycogen protects inflammation induced by urban particulate matter in normal human epidermal keratinocytes

    by Tomoya Kitakaze, Yasukiyo Yoshioka, Takashi Furuyashiki, Hitoshi Ashida

    Urban particulate matters (PM) exposure is significantly correlated with extrinsic skin aging signs and skin cancer incidence. PM contains polycyclic aromatic hydrocarbons, and they act as the agonists of aryl hydrocarbon receptor (AhR). Activation of AhR promotes generation of intracellular reactive oxygen species (ROS) and inflammation. Enzymatically synthesized glycogen (ESG), which is synthesized from starch, possesses various functions, such as anti-tumor, anti-obesity and antioxidant. However, the effects of ESG on PM-induced skin inflammation remain unclear. In this study, we investigated whether ESG has a protective effect on PM-induced oxidative stress and inflammation in human epidermal keratinocytes. ESG inhibited PM-induced expression of inflammatory cytokines IL6, TNFA and PTGS2. ESG also inhibited PM-induced phosphorylation of MAPKs and ROS accumulation. However, ESG had no effect on PM-induced expression of CYP1A1, one of the target proteins of AhR. On the other hand, ESG increased nuclear translocation of Nrf2 and expression of antioxidant proteins, HO-1 and NQO1. These results suggest that ESG suppressed PM-induced inflammation by decreasing ROS accumulation through the Nrf2 pathway.